JPH0355448B2 - - Google Patents

Info

Publication number
JPH0355448B2
JPH0355448B2 JP56050014A JP5001481A JPH0355448B2 JP H0355448 B2 JPH0355448 B2 JP H0355448B2 JP 56050014 A JP56050014 A JP 56050014A JP 5001481 A JP5001481 A JP 5001481A JP H0355448 B2 JPH0355448 B2 JP H0355448B2
Authority
JP
Japan
Prior art keywords
mice
granulosum
therapeutic agent
strain
avidum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56050014A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57165319A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS57165319A publication Critical patent/JPS57165319A/ja
Publication of JPH0355448B2 publication Critical patent/JPH0355448B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP56050014A 1980-03-25 1981-04-02 Manufacture of cell-wall or whole cell medicine in tumor radiative or chemical treatment Granted JPS57165319A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3011461A DE3011461C2 (de) 1980-03-25 1980-03-25 Verwendung von Propionibakterien

Publications (2)

Publication Number Publication Date
JPS57165319A JPS57165319A (en) 1982-10-12
JPH0355448B2 true JPH0355448B2 (enExample) 1991-08-23

Family

ID=6098254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56050014A Granted JPS57165319A (en) 1980-03-25 1981-04-02 Manufacture of cell-wall or whole cell medicine in tumor radiative or chemical treatment

Country Status (13)

Country Link
US (1) US4647456A (enExample)
JP (1) JPS57165319A (enExample)
AT (1) AT371714B (enExample)
AU (1) AU548596B2 (enExample)
BE (1) BE888770A (enExample)
CA (1) CA1197798A (enExample)
CH (1) CH661868A5 (enExample)
DE (1) DE3011461C2 (enExample)
FR (1) FR2505186A1 (enExample)
GB (1) GB2098478B (enExample)
NL (1) NL189947C (enExample)
NO (1) NO162079C (enExample)
SE (1) SE450088B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678773A (en) * 1983-08-26 1987-07-07 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
DE3817762A1 (de) * 1988-05-26 1989-11-30 Sanum Kehlbeck Gmbh & Co Kg Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
DE19630230A1 (de) * 1996-07-26 1998-01-29 Bayer Ag Herstellung immunstimulierender Mittel auf Basis von Propionibakterien
FR2764802A1 (fr) * 1996-12-24 1998-12-24 Standa Lab Sa Composition adsorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal
CA2299548C (en) 1997-08-05 2009-12-29 Bioniche Inc. Composition and method for regulating cell proliferation and cell death
US7709537B1 (en) * 1999-10-19 2010-05-04 Meiji Dairiese Corporation Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials
JP4772245B2 (ja) * 1999-12-13 2011-09-14 バイオニケ ライフ サイエンシーズ インコーポレイテッド 治療上有用な合成オリゴヌクレオチド
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
GB2623078B (en) * 2022-10-03 2025-04-16 Univ Brunel Prevention and/or treatment of wound infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2269961B1 (enExample) * 1974-05-06 1978-03-24 Anvar
FR2269962B1 (enExample) * 1974-05-06 1978-02-03 Anvar
JPS5215894A (en) * 1975-07-29 1977-02-05 Yuichi Yamamura Process for preparing a substance possessing biological actions
JPS5946206B2 (ja) * 1975-10-08 1984-11-10 （株） 目黒研究所 免疫学的活性を有する非病原性好気性コリネバクテリウム培養物の製造法
JPS52108091A (en) * 1976-03-03 1977-09-10 Kowa Co Production of antiitumor substance
JPS5411233A (en) * 1977-06-28 1979-01-27 Asahi Chem Ind Co Ltd Anitidote
JPS5513204A (en) * 1978-06-28 1980-01-30 Mitsui Toatsu Chem Inc Active compound having delayed allergic activity and anticarcinogenic activity, and its preparation
JPS55114290A (en) * 1979-02-27 1980-09-03 Mitsui Toatsu Chem Inc Substance with antitumorigenic activity, its production and medical preparation

Also Published As

Publication number Publication date
BE888770A (fr) 1981-11-12
GB2098478A (en) 1982-11-24
ATA118981A (de) 1982-10-15
US4647456A (en) 1987-03-03
GB2098478B (en) 1985-02-20
AU7024281A (en) 1982-11-11
CH661868A5 (de) 1987-08-31
AU548596B2 (en) 1985-12-19
SE450088B (sv) 1987-06-09
FR2505186B1 (enExample) 1984-10-12
NO162079B (no) 1989-07-24
NL8101452A (nl) 1982-10-18
NO162079C (no) 1989-11-01
NL189947C (nl) 1993-09-16
DE3011461A1 (de) 1981-10-01
CA1197798A (en) 1985-12-10
JPS57165319A (en) 1982-10-12
NO810815L (no) 1982-09-13
AT371714B (de) 1983-07-25
NL189947B (nl) 1993-04-16
DE3011461C2 (de) 1986-10-30
FR2505186A1 (fr) 1982-11-12
SE8101582L (sv) 1982-09-13

Similar Documents

Publication Publication Date Title
Kimura et al. Immunochemotherapy in human lung cancer using the streptococcal agent OK‐432
Rosenberg Immunotherapy of cancer using interleukin 2: current status and future prospects
DK168755B1 (da) Farmaceutisk præparat til diagnose og terapi af tumorer samt til behandling af svækkelser af celle- og humoral-immunforsvar
Cameron et al. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.
Milas et al. Corynebacterium granulosum-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice
JPH0355448B2 (enExample)
EP0593625B1 (en) Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity
Burton et al. In vitro induction of tumor-specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens
Hultborn et al. Irradiation of skin tumours during pure oxygen inhalation
Schwarzenberg et al. Human toxicology of BCG applied in cancer immunotherapy
Hattori et al. Five-year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C, and/or allogeneic bone marrow transplantation
CA2383626A1 (en) Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
US4479935A (en) Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
YAMAMURA et al. SUCCESSFUL TREATMENT OF THE PATIENTS WITH MALIGNANT PLEURAL EFFUSION WITH BCG CELL-WALL SKELTEON
CN110859859A (zh) 一种含有固定细菌的抗肿瘤组合物及其应用
Grigg et al. G-CSF stimulated donor granulocyte collections for neutropenic sepsis
UA78215C2 (en) Preparation possessing anticancer, detoxifying, and radioprotection activities
Arika et al. Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice
SU1304736A3 (ru) Способ получени противоопухолевого средства
Wilson et al. Dimethyl ether of D-tubocurarine iodide as a curarizing agent in anaesthesia for thoracic surgery
CN107375299A (zh) 一种积雪草酸的新用途及含积雪草酸的抗肿瘤药物组合
Murthy et al. Pre‐, peri‐, and postoperative chemotherapy for breast cancer: Is one better than the other?
CN120478384A (zh) 治疗结直肠癌的方法
Yarkoni et al. Immunotherapy of a guinea pig hepatoma with mycobacterial vaccines: Comparison of BCG cell walls and cell wall skeletons
FI75094C (fi) Foerfarande foer framstaellning av propionibacterium granulosum, propionibacterium avidum och/eller propionibacterium acnes cellvaeggs- eller helcellsprodukter.